Search
for
Sort by
Research 91–120 of 518
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Ectopic Sebaceous Glands in the Hair Follicle Matrix: Case Reports and Literature Review of this Embryogenic Anomaly
- Dermatologic Adverse Events from Cancer Treatments
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Atypical Morphological Patterns of Topical Steroid-Modified Dermatophytosis: A Cross-Sectional Study in South Asia
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Pharmacotherapy of alopecia areata
- Vaping Culture and Cutaneous Health: A Trend with Skin-Deep Consequences
- Acne-Associated Syndromes
- Cutaneous Lupus Erythematosus
- British Society for Dermatopathology
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Scalp Itch: A Systematic Review
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Primary Cicatricial Alopecias
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Psychotropic Medications and the Skin
- Diseases of Periocular Hair
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Acne in hirsute women
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases